Angiotensin II-mediated protein kinase D activation stimulates aldosterone and cortisol secretion in H295R human adrenocortical cells

被引:50
作者
Romero, Damian G.
Welsh, Bronwyn L.
Gomez-Sanchez, Elise P.
Yanes, Licy L.
Rilli, Silvia
Gomez-Sanchez, Celso E.
机构
[1] Univ Mississippi, Med Ctr, Dept Med, Div Endocrinol, Jackson, MS 39216 USA
[2] Univ Mississippi, Med Ctr, Montgomery Vet Affairs Med Ctr, Jackson, MS 39216 USA
[3] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA
[4] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA
关键词
D O I
10.1210/en.2006-0794
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Protein kinases are important mediators in intracellular signaling. Angiotensin II is the most important modulator of adrenal zona glomerulosa cell physiology. Angiotensin II regulates steroidogenesis and proliferation among many other metabolic processes. H295R human adrenal cells are a widely used experimental model to study adrenal cell physiology and metabolism. We screened for protein kinase expression levels using the Kinetwork system in H295R cells after 3 h angiotensin II treatment. Protein kinase D (PKD) was the protein kinase that suffers the most dramatic changes. PKD is a member of a new class of serine/threonine protein kinases that is activated by phosphorylation. Our studies indicated that angiotensin II time- and dose-dependently increased PKD phosphorylation, which occurred within 2 min of angiotensin II treatment and at concentrations as low as 1 nM. PKD phosphorylation was also dose-dependently increased by the PKC activator phorbol 12-myristate 13-acetate. Angiotensin II-mediated PKD phosphorylation was blocked by several PKC inhibitors. Furthermore, PKC epsilon translocation inhibitor peptide decreased angiotensin II-mediated PKD phosphorylation, and PKC epsilon down-regulation by RNA interference also decreased PKD phosphorylation mediated by angiotensin II. Co-transfection of constitutively active PKD mutant constructs up-regulated aldosterone synthase and 11 beta-hydroxylase expression in reporter assays. Constitutively active PKD mutants increased aldosterone and cortisol secretion under angiotensin II stimulatory conditions. This study reveals that PKD is an intracellular signaling mediator of angiotensin II regulation of steroidogenesis in human adrenal cells. These data provide new insights into the molecular mechanisms involved in angiotensin II-induced physiological and pathophysiological events in adrenal cells.
引用
收藏
页码:6046 / 6055
页数:10
相关论文
共 54 条
[1]   Rapid activation of the novel serine/threonine protein kinase, protein kinase D by phorbol esters, angiotensin II and PDGF-BB in vascular smooth muscle cells [J].
Abedi, H ;
Rozengurt, E ;
Zachary, I .
FEBS LETTERS, 1998, 427 (02) :209-212
[2]   ROLE OF CALCIUM IN ANGIOTENSIN II-MEDIATED ALDOSTERONE SECRETION [J].
BARRETT, PQ ;
BOLLAG, WB ;
ISALES, CM ;
MCCARTHY, RT ;
RASMUSSEN, H .
ENDOCRINE REVIEWS, 1989, 10 (04) :496-518
[3]   HUMAN NCI-H295 ADRENOCORTICAL CARCINOMA-CELLS - A MODEL FOR ANGIOTENSIN-II-RESPONSIVE ALDOSTERONE SECRETION [J].
BIRD, IM ;
HANLEY, NA ;
WORD, RA ;
MATHIS, JM ;
MCCARTHY, JL ;
MASON, JI ;
RAINEY, WE .
ENDOCRINOLOGY, 1993, 133 (04) :1555-1561
[4]   Protein kinase D and keratinocyte proliferation [J].
Bollag, WB ;
Dodd, ME ;
Shapiro, BA .
DRUG NEWS & PERSPECTIVES, 2004, 17 (02) :117-126
[5]   Protein kinase Cμ regulation of the JNK pathway is triggered via phosphoinositide-dependent kinase 1 and protein kinase Cε [J].
Brändlin, I ;
Eiseler, T ;
Salowsky, R ;
Johannes, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (47) :45451-45457
[6]   PKD in intestinal epithelial cells: rapid activation by phorbol esters, LPA, and angiotensin through PKC [J].
Chiu, T ;
Rozengurt, E .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (04) :C929-C942
[7]   Intraadrenal interactions in the regulation of adrenocortical steroidogenesis [J].
Ehrhart-Bornstein, M ;
Hinson, JP ;
Bornstein, SR ;
Scherbaum, WA ;
Vinson, GP .
ENDOCRINE REVIEWS, 1998, 19 (02) :101-143
[8]  
EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982
[9]  
GANGULY A, 1994, PHARMACOL REV, V46, P417
[10]  
Gomez-Sanchez C E, 1987, Steroids, V49, P581, DOI 10.1016/0039-128X(87)90097-3